Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank78
3Y CAGR-78.0%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-78.0%/yr
Quarterly compound
Percentile
P78
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 49.56% |
| Q3 2025 | -2.41% |
| Q2 2025 | 31.86% |
| Q1 2025 | 18.94% |
| Q4 2024 | 37.00% |
| Q3 2024 | 18.69% |
| Q2 2024 | 45.64% |
| Q1 2024 | 118.89% |
| Q4 2023 | 693.84% |
| Q3 2023 | 572.78% |
| Q2 2023 | -114.08% |
| Q1 2023 | -76.61% |
| Q4 2022 | 4649.76% |
| Q3 2022 | -101.43% |
| Q2 2022 | 2816.01% |
| Q1 2022 | 39.78% |
| Q4 2021 | -69.19% |
| Q3 2021 | -94.48% |
| Q2 2021 | -33.78% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |